Abbvie reported $4.28B in Cost of Sales for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
AstraZeneca AZN:LN 3068M 756M
Eisai 4523:JP Y 44222M 3601M
Horizon Pharma HZNP:US $ 241.51M 10.13M
Intercept Pharmaceuticals ICPT:US $ 1.01M 0.36M
JAZZ PHA JAZZ:US $ 136.15M 9.07M
Medtronic MDT:US $ 2459M 7M
Neurocrine Biosciences NBIX:US $ 4.1M 0.1M
Novartis NOVN:VX SF 4000M 152M
Pacira Pharmaceuticals PCRX:US $ 39.01M 4.36M
Pfizer PFE:US $ 9703M 228M
Regeneron Pharmaceuticals REGN:US $ 982.6M 529.4M
Revance Therapeutics RVNC:US $ 7.88M 2M
Teva Pharmaceutical Industries TEVA:US $ 1975M 14M
Ultragenyx Pharmaceutical RARE:US $ 3.51M 0.67M
United Therapeutics UTHR:US $ 34.6M 6.9M
Vertex Pharmaceuticals VRTX:US $ 247.39M 10.88M
Zoetis ZTS:US $ 596M 14M